Tazarotene Topical
Tazarotene is a topical retinoid used to help reduce the appearance of fine facial wrinkles, uneven skin tone, and certain benign facial spots.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 18 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Tazarotene cream is a retinoid (a vitamin A relative) used nightly on the face to soften fine wrinkles, blotchy pigmentation and benign sun spots; on the market since about 1997 and available as a generic, it is generally regarded as one of the stronger topical retinoids. Dryness, peeling, redness and stinging are common, especially in the first few weeks. The biggest concern is pregnancy, because retinoids can cause birth defects, so anyone who could become pregnant needs a negative pregnancy test first and reliable birth control throughout. It softens wrinkles rather than erasing them or reversing sun damage, and daily sunscreen is part of the treatment.
Clinical pearls
- If you could become pregnant, start during a menstrual period, and stop immediately and call your prescriber if pregnancy happens.
- Remove makeup, let your face dry completely, apply a pea-sized amount at bedtime, then wash your hands.
- If peeling or burning gets rough, apply less often or pause until it settles, and never apply over sunburned or windburned skin.
- Go easy on harsh or drying cleansers, and mention tazarotene before starting sun-sensitizing drugs like tetracyclines or thiazide water pills.
Patient information guide A plain-language walkthrough of Tazarotene Topical, written from its FDA label.
What Tazarotene Topical is used for
▾
Tazarotene topical is a retinoid used on the skin of the face. The specific approved uses depend on the product and formulation:
- Tazarotene cream 0.1% is indicated as an adjunctive (supporting) treatment for facial fine wrinkles, mottled skin discoloration (uneven lighter or darker patches), and benign facial lentigines (flat pigmented spots) in patients who also follow a comprehensive skin care and sun avoidance program
- This use requires a physician to evaluate any pigmented facial lesions of concern before starting treatment
- Tazarotene cream does not eliminate or prevent wrinkles, restore more youthful-looking skin, or repair sun-damaged skin
- It has not been shown to prevent or treat actinic keratoses (precancerous lesions), skin cancers, or lentigo maligna
How Tazarotene Topical works
▾
Tazarotene is a retinoid prodrug — meaning your skin converts it into its active form, called tazarotenic acid, after it's applied. That active form binds to retinoic acid receptors (RARs) inside skin cells, particularly two subtypes called RARβ and RARγ. By attaching to these receptors, it may influence how certain genes in the skin behave. The exact chain of events that leads to improvements in wrinkles and skin tone is not fully understood.
Tazarotene Topical dosage
▾
Tazarotene cream is applied topically to the face once each day at bedtime. Remove makeup first; dry your skin before applying after washing. Use only a pea-sized amount spread lightly over the entire face — including the eyelids if desired. Hands should be washed after every application.
- Moisturizers or emollients can be used before or after, but let each product absorb and dry completely before applying the next
- Use sunscreen and wear protective clothing during the day throughout treatment
- Avoid contact with eyes, mouth, or other mucous membranes; rinse thoroughly with water if accidental contact occurs
- Follow your prescriber's specific instructions — do not use more than directed, as overuse can cause marked redness, peeling, and discomfort
Dosing details from the FDA-approved label
From the Tazarotene Topical prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Tazarotene cream, topical use on the face
- Apply a pea-sized amount to lightly cover the entire face once daily at bedtime, including the eyelids, if desired
- Obtain a pregnancy test within 2 weeks prior to therapy and initiate during a menstrual period; remove any makeup and dry the skin before applying; not for ophthalmic, oral, or intravaginal use
Read the label’s full dosing text
2 DOSAGE AND ADMINISTRATION Apply a pea-sized amount of tazarotene cream to lightly cover the entire face once daily at bedtime. ( 2 ) If contact with eyes occurs, rinse thoroughly with water. ( 2 ) Not for ophthalmic, oral, or intravaginal use. ( 2 ) 2.1 Assessment Prior to Treatment Initiation Obtain a pregnancy test within 2 weeks prior to tazarotene cream therapy. Initiate tazarotene cream therapy during a menstrual period [see Contraindications (4) , Warnings and Precautions (5.1) , and Use in Specific Populations (8.1 , 8.3) ] . Carefully assess facial pigmented lesions of concern by a qualified physician (e.g., dermatologist) before application of tazarotene cream [see Warnings and Precautions (5.4) ] . 2.2 Important Administration Instructions Avoid accidental transfer of tazarotene cream into eyes, mouth, or other mucous membranes. If contact with mucous membranes occurs, rinse thoroughly with water [see Warnings and Precautions (5.2) ] . Wash hands thoroughly after application. Emollients or moisturizers can be applied either before or after applying tazarotene cream. However, ensure that the first cream or lotion has absorbed into the skin and has dried completely before subsequent cream or lotion application. Use facial moisturizers as frequently as desired [see Warnings and Precautions (5.2) ]. Tazarotene cream is for topical use only. Tazarotene cream is not for ophthalmic, oral, or intravaginal use. Use effective sunscreens and wear protective clothing while using tazarotene cream [see Warnings and Precautions (5.3) ]. 2.3 Dosage and Administration Instructions Remove any makeup before applying tazarotene cream to the face. Dry the skin before applying the cream after face washing, bathing, or showering. Apply a pea-sized amount once a day at bedtime to lightly cover the entire face, including the eyelids, if desired. Wash hands thoroughly after application.
Read the full Dosage and Administration section on DailyMed →
Tazarotene Topical side effects
▾
Most side effects happen right at the skin where you apply tazarotene. Common reactions include:
Common side effects
- Skin peeling or flaking (desquamation)
- Burning or stinging at the application site
- Redness (erythema)
- Itching (pruritus)
- Dry skin
- Skin irritation
- Skin discoloration
When to get medical help
- Stop using and contact your doctor if you have severe skin blistering, peeling, or raw skin
- Call your doctor if you develop a skin rash, hives (urticaria), or signs of an allergic reaction
- Get medical help immediately if you are or become pregnant while using this medication — it can cause serious harm to an unborn baby
- Seek care if you experience significant sunburn — do not use the cream until your skin has fully healed
- Contact your doctor if you notice extreme redness, swelling, or pain at the application site
If you develop severe blistering, widespread peeling, hives, or any signs of an allergic reaction, stop using the cream and contact your doctor right away. These can be signs of a serious reaction that needs medical attention.
Tazarotene Topical warnings and precautions
▾
- Pregnancy risk: Tazarotene is a retinoid and can cause serious birth defects. It is completely contraindicated (must not be used) during pregnancy. If you can become pregnant, use effective contraception during treatment, get a pregnancy test within 2 weeks before starting, and begin therapy during a menstrual period. Stop immediately if you become pregnant and call your doctor.
- Sun sensitivity: Tazarotene makes your skin much more vulnerable to sunburn. Wear sunscreen daily and cover up. Avoid sunlamps. Do not use the cream if your skin is sunburned — wait until fully healed. Extra caution is needed if you take medications that also increase sun sensitivity (see Interactions).
- Skin irritation: Burning, redness, peeling, and itching are common, especially early on. If irritation is severe, reduce how often you apply it or take a break until skin recovers. Do not use on eczematous (inflamed, eczema-affected) skin — it can cause severe irritation. Avoid harsh or strongly drying skin products during treatment.
- Allergic reactions: Stop use and seek care if you notice hives, blistering, or signs of a hypersensitivity reaction.
Tazarotene Topical interactions
▾
There are no formal drug interaction studies for topical tazarotene, but a few important considerations apply:
- Photosensitizing drugs — medications that increase sun sensitivity, such as thiazide diuretics, tetracycline antibiotics, fluoroquinolone antibiotics, phenothiazine antipsychotics, and sulfonamides — may further increase your risk of sunburn when used alongside tazarotene; your doctor should be aware if you take any of these
- Harsh or drying topical products — cosmetics or skin medications with strong drying effects can worsen skin irritation; they should be avoided or used cautiously
- Oral contraceptives — in one study using oral tazarotene, tazarotenic acid did not affect the blood levels of norethindrone or ethinyl estradiol (common birth control hormones); the effect on progestin-only (minipill) contraceptives has not been studied
Interactions listed in the FDA-approved label
From the Tazarotene Topical prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
- Combination oral contraceptive tablet (1 mg norethindrone and 35 mcg ethinyl estradiol): Concomitant use of tazarotene administered as 1.1 mg orally did not affect the pharmacokinetics of norethindrone and ethinyl estradiol over a complete cycle.
- Progestin only oral contraceptives (i.e., minipills): The impact of tazarotene on the pharmacokinetics of progestin only oral contraceptives has not been evaluated.
Read the label’s full interactions text
7 DRUG INTERACTIONS No formal drug-drug interaction studies were conducted with tazarotene gel. In a trial of 27 healthy female subjects between the ages of 20–55 years receiving a combination oral contraceptive tablet containing 1 mg norethindrone and 35 mcg ethinyl estradiol, concomitant use of tazarotene administered as 1.1 mg orally (mean ± SD C max and AUC 0-24 of tazarotenic acid were 28.9 ± 9.4 ng/mL and 120.6 ± 28.5 ng•hr/mL, respectively) did not affect the pharmacokinetics of norethindrone and ethinyl estradiol over a complete cycle. The impact of tazarotene on the pharmacokinetics of progestin only oral contraceptives (i.e., minipills) has not been evaluated.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Tazarotene Topical
▾
- Pregnancy: Do not use if you are pregnant — risk of serious fetal malformations. Use reliable birth control and be tested for pregnancy before starting.
- Breastfeeding: It is not known whether tazarotene passes into human breast milk. Discuss the risks and benefits with your doctor before using while breastfeeding.
- Children: Safety and effectiveness have not been established in patients under age 17 for the wrinkle and pigmentation indications.
- Older adults: No significant differences in safety or effectiveness were found in patients over 65, though some individuals may be more sensitive.
- Allergies: Do not use if you are allergic to tazarotene or any ingredient in the formulation.
- Skin conditions: Do not apply to skin affected by eczema — this can cause severe irritation. Avoid use on sunburned or windburned skin until fully healed.
- Sun exposure: Tell your doctor if your job or daily life involves heavy sun exposure — you'll need extra precautions.
- Pigmented skin lesions: Have any concerning facial spots evaluated by a qualified physician (such as a dermatologist) before beginning treatment.
Tazarotene Topical overdose
▾
Using too much tazarotene cream on the skin can cause marked redness, peeling, and significant discomfort. If the cream is accidentally swallowed, it can cause effects similar to taking too much vitamin A (a condition called hypervitaminosis A) or other retinoids taken by mouth. If accidental ingestion occurs, contact a poison control center or seek medical care right away, and follow any supportive measures your healthcare provider recommends.
How your body processes Tazarotene Topical
▾
After tazarotene cream is applied to the skin, the body's natural enzymes convert it into its active form — tazarotenic acid. Very little of the original compound enters the bloodstream. The active form binds tightly to proteins in the blood (more than 99%) and has a half-life of roughly 18 hours, meaning it takes about that long for the body to clear half of it. Both tazarotene and tazarotenic acid are broken down into other compounds and cleared from the body through urine and stool. The amount that reaches the bloodstream depends on how large an area of skin is treated — covering a bigger area of the body leads to significantly higher blood levels than applying it to the face alone.
How to store Tazarotene Topical
▾
Store at 20°C to 25°C (68°F to 77°F).
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Supplements & herbs that interact with Tazarotene Topical
24 supplements and herbal products have documented interactions with Tazarotene Topical in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 1
- Moderate · 21
- Minor · 2
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Tazarotene Topical has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
Tazarotene Topical: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Tazarotene Topical — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly does tazarotene cream do for my skin?
▾
How do I apply it correctly?
▾
My skin is burning and peeling — is that normal, and what should I do?
▾
Can I use tazarotene if I'm pregnant or thinking about getting pregnant?
▾
Do I need to be extra careful in the sun while using this?
▾
Are there any medications or skin products I should avoid while using tazarotene?
▾
Is Tazarotene Topical available over the counter?
▾
When was Tazarotene Topical first available?
▾
Who makes Tazarotene Topical?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Tazarotene Topical on HelloPharmacist
Tazarotene Topical forms and strengths (how it comes)
Tazarotene Topical is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Topical cream, ointment or gel
How this form is used
- Tazarotene cream 0.1% is used as an adjunctive (add-on) treatment to help reduce facial fine wrinkles, mottled skin discoloration, and benign facial lentigines (flat facial spots) in adults following a comprehensive skin care and sun avoidance program
- This form does not eliminate wrinkles or reverse sun-damaged skin, and is not established for treating precancerous skin lesions or skin cancer
- Apply a pea-sized amount once daily at bedtime to lightly cover the entire face; remove makeup and dry skin before applying
- Wash hands thoroughly after each application
- Moisturizers may be applied before or after — allow each product to fully absorb and dry before applying the next
- Use sunscreen and protective clothing daily during treatment; avoid sunlamps and prolonged sun exposure
Inhaler
Tazarotene Topical on the U.S. market: products, makers and brands
How Tazarotene Topical appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
10 companies list 22 Tazarotene Topical product records with the FDA, mostly as topical cream, ointment or gel, inhaler; the earliest marketing or approval year on record is 1997. Brand names on the directory include Avage, Fabior, Tazorac and 2 more; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Tazarotene Topical is used (Medicaid data)
A general measure of how commonly Tazarotene Topical is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Tazarotene Topical is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Tazarotene Topical prescribed? Of the 1,601 medications we measure, Tazarotene Topical ranks #730 by Medicaid prescriptions — more than 54% of them.
Utilization by Tazarotene Topical product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
tazarotene 1 MG/ML Topical Cream Most dispensed
Summed across the 5 of 12 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 313200
tazarotene 0.45 MG/ML Topical Lotion
Summed across the 1 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2267561
tazarotene 0.5 MG/ML Topical Cream
Summed across the 4 of 6 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 314268
tazarotene 0.0005 MG/MG Topical Gel
Summed across the 6 of 10 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 313199
tazarotene 0.001 MG/MG Topical Gel
Summed across the 6 of 12 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 313201
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Tazarotene Topical, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 22 of 43 listed Tazarotene Topical NDCs with Medicaid activity.
Compare Tazarotene Topical products
A representative set of FDA-listed product records for Tazarotene Topical — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Inhaler | ||||
| 1 mg/g | Topical | Mayne Pharma | NDA | View NDC → |
| 1 mg/g | Topical | Mayne Pharma Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 💊Topical cream, ointment or gel | ||||
| 0.05 mg/g | Cutaneous | Almirall, LLC | NDA | View NDC → |
| 0.1 mg/g | Cutaneous | Almirall, LLC | NDA | View NDC → |
| 0.5 mg/g | Cutaneous | Almirall, LLC | NDA | View NDC → |
| 1 mg/g | Cutaneous | Almirall, LLC | NDA | View NDC → |
| 0.45 mg/g | Topical | Bausch Health US, LLC | NDA | View NDC → |
| 0.5 mg/g | Topical | Bryant Ranch Prepack | ANDA | View NDC → |
| 1 mg/g | Topical | Bryant Ranch Prepack | ANDA | View NDC → |
| 0.5 mg/g | Topical | Cosette Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 1 mg/g | Topical | Cosette Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 1 mg/g | Topical | Mayne Pharma | ANDA | View NDC → |
| 0.5 mg/g | Topical | Padagis Israel Pharmaceuticals Ltd × 2 listings | ANDA | View NDC → |
| 1 mg/g | Topical | Padagis Israel Pharmaceuticals Ltd | ANDA | View NDC → |
| 1 mg/g | Topical | Perfero Pharma, Inc. | ANDA | View NDC → |
| 0.5 mg/g | Cutaneous | Solaris Pharma Corporation | ANDA | View NDC → |
| 1 mg/g | Cutaneous | Solaris Pharma Corporation | ANDA | View NDC → |
| 1 mg/g | Topical | Sun Pharmaceutical Industries, Inc. × 2 listings | ANDA | View NDC → |
Showing 22 of 22 products — FDA National Drug Code Directory. See every product, package size and price: browse all 22 Tazarotene Topical NDCs →
Tazarotene Topical side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Tazarotene Topical — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Tazarotene Topical in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Tazarotene Topical FDA approval history
How Tazarotene Topical went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Tazarotene Topical recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Tazarotene recalls since July 2021.
✅No Tazarotene recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 83947 4 dose forms · 6 strengths
-
Dose form (SCDF) Topical Cream RxCUI 378678In current FDA listings -
Dose form (SCDF) Topical Foam RxCUI 1293450In current FDA listingsClinical drug / strength (SCD) 1 MG/MLRxCUI 1293451 -
Dose form (SCDF) Topical Gel RxCUI 379083In current FDA listings -
Dose form (SCDF) Topical Lotion RxCUI 2267560In current FDA listingsClinical drug / strength (SCD) 0.45 MG/MLRxCUI 2267561
Look up RxCUI 83947 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Tazarotene Topical supply and shortage status
Whether Tazarotene Topical is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
💵 What Tazarotene Topical costs pharmacies (NADAC benchmark)
The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.
| Form | Strength | Pharmacy acquisition benchmark | |
|---|---|---|---|
| Cream · Topical | 1 mg/g | $1.85–$1.92 per gram | NDC details & price history |
| Cream · Topical | 0.5 mg/g | $6.89–$8.07 per gram | NDC details & price history |
| Gel · Topical | 1 mg/g | $5.71–$6.50 per gram | NDC details & price history |
| Gel · Topical | 0.5 mg/g | $5.31 per gram | NDC details & price history |
| Aerosol, Foam · Topical | 1 mg/g | $12.32 per gram | NDC details & price history |
| Lotion · Topical | 0.45 mg/g | $11.32 per gram | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.
Tazarotene Topical brand names
Tazarotene Topical is sold under 5 brand names in the FDA directory — Avage, Fabior, Tazorac, Arazlo and others. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Tazarotene Topical: manufacturers and labelers
10 companies list Tazarotene Topical products with the FDA. By number of product records, the largest are Almirall, LLC, Cosette Pharmaceuticals, Inc., Padagis Israel Pharmaceuticals Ltd. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Tazarotene Topical drug class (RxNorm)
Tazarotene Topical belongs to the Retinoid class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Tazarotene Topical page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Almirall, LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →